| Name | PNU-248686A | 
|---|---|
| Synonyms | 
                                
                                Sodium (2R)-3-[(4'-chloro-4-biphenylyl)sulfonyl]-2-hydroxy-2-[(phenylsulfanyl)methyl]propanoate
                                
                                
                                 Propanoic acid, 3-[(4'-chloro[1,1'-biphenyl]-4-yl)sulfonyl]-2-hydroxy-2-[(phenylthio)methyl]-, sodium salt, (2R)- (1:1)  | 
                        
| Description | PNU-248686A is a novel matrix metalloproteinase (MMP) inhibitor. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 MMP[1]  | 
                        
| In Vitro | PNU-248686A is an orally active matrix metalloproteinase (MMP) inhibitor developed for the treatment of solid tumors over-expressing MMPs[1]. | 
| References | 
| Molecular Formula | C22H19ClNaO5S2 | 
|---|---|
| Molecular Weight | 485.96 | 
| Storage condition | 2-8℃ |